March 9, 2026 · Form 4 insider transaction
Rothfuss Cristin sold 484 shares of Sarepta Therapeutics, Inc. at $16.95 per share, a transaction worth $8.2K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022.